Works matching DE "EXENATIDE"
Results: 536
Predictors of Use of Individual Insulin and GLP-1 RA Products Versus Fixed Ratio Insulin/GLP-1 RA Combinations in Medicare Beneficiaries.
- Published in:
- Senior Care Pharmacist, 2025, v. 40, n. 2, p. 97, doi. 10.4140/TCP.n.2025.97
- By:
- Publication type:
- Article
hUCMSCs carrying exenatide prevent T1DM by improving intestinal microflora composition and islet tissue damage repair.
- Published in:
- Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00526-0
- By:
- Publication type:
- Article
Exenatide regulates Th17/Treg balance via PI3K/Akt/FoxO1 pathway in db/db mice.
- Published in:
- Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00574-6
- By:
- Publication type:
- Article
Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 1, p. 167, doi. 10.3906/sag-2004-154
- By:
- Publication type:
- Article
Updates from EASD 2017.
- Published in:
- Diabetes & Primary Care, 2017, v. 19, n. 5, p. 190
- Publication type:
- Article
Hyperglycaemia in type 2 diabetes: Newer blood glucose-lowering therapies.
- Published in:
- Diabetes & Primary Care, 2015, v. 17, n. 6, p. 302
- By:
- Publication type:
- Article
Hyperglycaemia in type 2 diabetes: Newer blood glucose-lowering therapies - update.
- Published in:
- Diabetes & Primary Care, 2012, v. 14, n. 2, p. 102
- By:
- Publication type:
- Article
Erratum: 'Effects of exenatide on glycemia and renal water and ion excretion differ in frogs and rats'.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
Effects of exenatide on glycemia and renal water and ion excretion differ in frogs and rats.
- Published in:
- Journal of Evolutionary Biochemistry & Physiology, 2016, v. 52, n. 3, p. 228, doi. 10.1134/S0022093016030054
- By:
- Publication type:
- Article
OP46 Assessing The Quality Of Pharmacoeconomic Evaluations About Type 2 Diabetes Mellitus Drugs In National Reimbursement Drug List.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Eksenatidin 3D 3T3-L1 Adipositleri Üzerindeki Ekspresyon Profilinin Mikrodizin Analizi ile Belirlenmesi.
- Published in:
- Journal of the Institute of Science & Technology / Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 2022, v. 12, n. 4, p. 1995, doi. 10.21597/jist.1143528
- By:
- Publication type:
- Article
Renal outcomes with the newer antidiabetes drugs: the era before and after CREDENCE.
- Published in:
- Diabetic Medicine, 2020, v. 37, n. 4, p. 593, doi. 10.1111/dme.14262
- By:
- Publication type:
- Article
Acute plasma amylase increase after glucagon-like peptide -1 receptor agonist exenatide administration in Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 4, p. 591, doi. 10.1111/dme.13160
- By:
- Publication type:
- Article
Clinical care and other categories posters: incretin therapies.
- Published in:
- Diabetic Medicine, 2016, v. 33, p. 145, doi. 10.1111/dme.36_13048
- Publication type:
- Article
The Association of British Clinical Diabetologists nationwide exenatide and liraglutide audits suggest a low incidence of acute pancreatitis. Response to Robson. Incretins and pancreatitis-what happens next? A personal viewpoint.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 12, p. 1510, doi. 10.1111/dme.12336
- By:
- Publication type:
- Article
The potential risks of pancreatitis and pancreatic cancer with GLP-1-based therapies are far outweighed by the proven and potential (cardiovascular) benefits.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 10, p. 1148, doi. 10.1111/dme.12301
- By:
- Publication type:
- Article
Primary-care observational database study of the efficacy of GLP-1 receptor agonists and insulin in the UK.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 6, p. 681, doi. 10.1111/dme.12137
- By:
- Publication type:
- Article
Late Breaking Abstracts.
- Published in:
- Diabetic Medicine, 2013, v. 30, p. E1, doi. 10.1111/dme.12170
- Publication type:
- Article
Response to Nandakoban et al. Acute tubulointerstitial nephritis following treatment with exenatide.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 2, p. 251, doi. 10.1111/dme.12014
- By:
- Publication type:
- Article
Reply to Rees et al. Acute tubulointerstitial nephritis following treatment with exenatide.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 2, p. 252, doi. 10.1111/dme.12054
- By:
- Publication type:
- Article
Acute tubulointerstitial nephritis following treatment with exenatide.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 1, p. 123, doi. 10.1111/j.1464-5491.2012.03738.x
- By:
- Publication type:
- Article
Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2012, v. 29, n. 12, p. 1515, doi. 10.1111/j.1464-5491.2012.03699.x
- By:
- Publication type:
- Article
A randomized non-inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with Type 2 diabetes experiencing inadequate glycaemic control on metformin and sitagliptin
- Published in:
- Diabetic Medicine, 2012, v. 29, n. 11, p. e417, doi. 10.1111/j.1464-5491.2012.03624.x
- By:
- Publication type:
- Article
Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti-diabetic medication: a follow-up study.
- Published in:
- Diabetic Medicine, 2012, v. 29, n. 11, p. 1412, doi. 10.1111/j.1464-5491.2012.03652.x
- By:
- Publication type:
- Article
Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study.
- Published in:
- Diabetic Medicine, 2012, v. 29, n. 10, p. 1260, doi. 10.1111/j.1464-5491.2012.03745.x
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 analogues and thyroid cancer: An analysis of cases reported in the European pharmacovigilance database.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 1, p. 99, doi. 10.1111/jcpt.13259
- By:
- Publication type:
- Article
Predictive factors associated with glycaemic response to exenatide in Chinese patients with type 2 diabetes mellitus.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 5, p. 1050, doi. 10.1111/jcpt.13134
- By:
- Publication type:
- Article
Safety and tolerability of once‐weekly GLP‐1 receptor agonists in type 2 diabetes.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, p. 43, doi. 10.1111/jcpt.13225
- By:
- Publication type:
- Article
Glycaemic and non‐glycaemic efficacy of once‐weekly GLP‐1 receptor agonists in people with type 2 diabetes.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, p. 28, doi. 10.1111/jcpt.13224
- By:
- Publication type:
- Article
Exenatide for obesity in children and adolescents: Systematic review and meta-analysis.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1290184
- By:
- Publication type:
- Article
Emerging role of antidiabetic drugs in cardiorenal protection.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1349069
- By:
- Publication type:
- Article
PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patients.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1088670
- By:
- Publication type:
- Article
Exenatide improves hepatocyte insulin resistance induced by different regional adipose tissue.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.1012904
- By:
- Publication type:
- Article
Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 01, doi. 10.3389/fendo.2022.949990
- By:
- Publication type:
- Article
Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.863592
- By:
- Publication type:
- Article
The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.677202
- By:
- Publication type:
- Article
Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.742873
- By:
- Publication type:
- Article
Evaluation of Exenatide Versus Insulin Glargine Treatment's Impact on Brown Adipose Tissue Markers and Epicardial Adipose Tissue.
- Published in:
- Medical Journal of Bakirkoy, 2023, v. 19, n. 3, p. 276, doi. 10.4274/BMJ.galenos.2023.2023.6-5
- By:
- Publication type:
- Article
Association of Time in Range with Endothelial Injury in Patients with Type 2 Diabetes Treated with Exenatide.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 10, p. 1755, doi. 10.1007/s13300-022-01310-3
- By:
- Publication type:
- Article
Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 4, p. 1511, doi. 10.1007/s13300-018-0449-6
- By:
- Publication type:
- Article
The Effects of Exenatide and Metformin on Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Case-Control Study.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1295, doi. 10.1007/s13300-018-0435-z
- By:
- Publication type:
- Article
Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 2, p. 551, doi. 10.1007/s13300-018-0370-z
- By:
- Publication type:
- Article
Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 1, p. 269, doi. 10.1007/s13300-017-0359-z
- By:
- Publication type:
- Article
Tolerability and Effectiveness of Exenatide Once Weekly Relative to Basal Insulin Among Type 2 Diabetes Patients of Different Races in Routine Care.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 6, p. 1349, doi. 10.1007/s13300-017-0314-z
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 2, p. 335, doi. 10.1007/s13300-017-0237-8
- By:
- Publication type:
- Article
Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 401, doi. 10.1007/s13300-016-0187-6
- By:
- Publication type:
- Article
Onset of Glycemic and Weight Outcomes in Patients Initiating Exenatide Once Weekly: The Relationship of Exenatide Exposure with Efficacy over the First 24 Weeks of Treatment.
- Published in:
- 2016
- By:
- Publication type:
- Report
Pharmacokinetics, in vitro and in vivo correlation, and efficacy of exenatide microspheres in diabetic rats.
- Published in:
- Drug Delivery, 2015, v. 22, n. 1, p. 86, doi. 10.3109/10717544.2013.871760
- By:
- Publication type:
- Article
Eosinophil-rich granulomatous panniculitis caused by exenatide injection.
- Published in:
- Journal of Cutaneous Pathology, 2014, v. 41, n. 1, p. 63, doi. 10.1111/cup.12246
- By:
- Publication type:
- Article